Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gina Jerome

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|February 24, 2017
Discovery of a Potent and Selective Sphingosine Kinase 1 Inhibitor through the Molecular Combination of Chemotype-Distinct Screening HitsMark E Schnute, Matthew D McReynolds, Jeffrey Carroll, et al.
Brain : a Journal of Neurology|September 14, 2017
Slow wave sleep disruption increases cerebrospinal fluid amyloid-β levelsYo-El S Ju, Sharon J Ooms, Courtney Sutphen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersAleksandra Beric, Wenjing Lin, Gina Jerome, et al.
Neurology|December 29, 2017
Associations between [<sup>18</sup>F]AV1451 tau PET and CSF measures of tau pathology in a clinical sampleRenaud La Joie, Alexandre Bejanin, Anne M Fagan, et al.
Annals of Clinical and Translational Neurology|October 24, 2018
Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectoryPeter A Ljubenkov, Adam M Staffaroni, Julio C Rojas, et al.
The Biochemical Journal|March 9, 2012
Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1Mark E Schnute, Matthew D McReynolds, Tom Kasten, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
Abnormalities in core AD biomarkers precede inflammatory and glial markers in CSF in Autosomal Dominant Alzheimer's DiseaseWenjing Lin, Aleksandra Beric, Julie K Wisch, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|February 24, 2017
Discovery of a Potent and Selective Sphingosine Kinase 1 Inhibitor through the Molecular Combination of Chemotype-Distinct Screening HitsMark E Schnute, Matthew D McReynolds, Jeffrey Carroll, et al.
Brain : a Journal of Neurology|September 14, 2017
Slow wave sleep disruption increases cerebrospinal fluid amyloid-β levelsYo-El S Ju, Sharon J Ooms, Courtney Sutphen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersAleksandra Beric, Wenjing Lin, Gina Jerome, et al.
Neurology|December 29, 2017
Associations between [<sup>18</sup>F]AV1451 tau PET and CSF measures of tau pathology in a clinical sampleRenaud La Joie, Alexandre Bejanin, Anne M Fagan, et al.
Annals of Clinical and Translational Neurology|October 24, 2018
Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectoryPeter A Ljubenkov, Adam M Staffaroni, Julio C Rojas, et al.
The Biochemical Journal|March 9, 2012
Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1Mark E Schnute, Matthew D McReynolds, Tom Kasten, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
Abnormalities in core AD biomarkers precede inflammatory and glial markers in CSF in Autosomal Dominant Alzheimer's DiseaseWenjing Lin, Aleksandra Beric, Julie K Wisch, et al.
Pageof 1